U.K. researchers develop experimental HIV vaccine; Pitt researchers target 'alphaviruses' with vaccines;

> the U.K. HIV Vaccine Consortium has developed an experimental HIV vaccine using a similar approach to that used to develop Ebola and malaria vaccines. News

> University of Pittsburgh researchers are working on drugs against "alphaviruses," a group of 30 viruses that are transmitted by mosquitoes. More

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.